Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion type Assertion NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_head.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion evidence source_evidence_literature NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion SIO_000772 22491195 NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion wasDerivedFrom befree-2016 NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.
- NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion wasGeneratedBy ECO_0000203 NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.